Allero Therapeutics
Rotterdam · Founded 2016
About Allero Therapeutics
Allero Therapeutics is a biopharmaceutical company that develops next generation immunotherapies for immune mediated disorders. Based on research by the founders and their collaborators the team has identified a novel specific immunotherapy approach based on antigen-specific tolerance induction. The approach defines a platform technology which is broadly applicable to a range of clinical indications with profound unmet medical need.
Company Facts
- Founded: 2016
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.0M
- Funding stage: Seed
- Last round: Grant (Oct 2021)
- Website: https://www.allerotherapeutics.com/
- Phone: [email protected]
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/allero-therapeutics-11400 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.